Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing Tourniquet Pain in Forearm Surgery Using Different Analgesia Techniques
NCT05602636Phase 4Recruiting
- Sponsor
- Al-Azhar University
- Start
- Dec 2022
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine and fentanyl (3 arms), sponsored by Al-Azhar University. Primary endpoint: The incidence of tourniquet pain at 2 hours. Started Dec 2022; status: recruiting.
02
Drugs
bupivacainefentanyl
Beyond the preview
Go deeper on NCT05602636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05602636.